Prospective Evaluation of Oral Gastrografin in Postoperative Small Bowel Obstruction

Kapoor, Sorabh; Jain, Gaurav; Sewkani, Ajit; Sharma, Sandesh; Patel, Kailash; Varshney, Subodh

doi:10.1016/j.jss.2005.12.008

Cited by 29 publications

(16 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgery was required in 96% of patients in whom contrast failed to reach the colon within 24 h. Assalia et al [8] and Biondo et al [11] reported that oral gastrografin facilitated quicker resolution of obstructive episode and decreased the duration of hospitalization, although Feigen et al [12] denied the therapeutic effect of gastrografin and did not find any advantage with regard to operative rate, resolution symptoms and hospital stay. Kapoor et al [23] conducted a prospective study administering gastrografin to patients who failed to improve after 48 h of conservative treatments, noting relief of obstruction in 22 of 24 patients.…”

Section: Discussionmentioning

confidence: 99%

Clinical Impacts of Oral Gastrografin Follow-Through in Adhesive Small Bowel Obstruction (SBO)

Farid¹,

Fikry²,

Nakeeb³

et al. 2010

Journal of Surgical Research

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Clinical Impacts of Oral Gastrografin Follow-Through in Adhesive Small Bowel Obstruction (SBO)

Farid¹,

Fikry²,

Nakeeb³

et al. 2010

Journal of Surgical Research

View full text Add to dashboard Cite

“…Some studies that show a decreased need for surgery have used GG after a 48-hour period of unsuccessful conservative management, and these studies have been conducted in an environment of low operative threshold. 6,10 Hence, when patients receive GG, they may be benefitting from the additional time spent pursuing nonoperative treatment rather than from the GG itself. A randomized controlled trial by Choi and colleagues 6 also showed a dramatically decreased need for surgery, but the random assignment of patients in this study was different from that in comparable studies.…”

Section: Periods 1 and 2 Combinedmentioning

confidence: 99%

Impact of Gastrografin in clinical practice in the management of adhesive small bowel obstruction

Srinivasa

Thakore

Abbas

et al. 2011

cjs

View full text Add to dashboard Cite

Background: Gastrografin (GG) has been shown to accelerate the resolution of adhesive small bowel obstruction (ASBO) and decrease length of stay (LOS) in hospital. Consequently, we instituted a protocol recommending the routine use of GG in patients with ASBO. This study reviews patient outcomes after protocol implementation. Methods:We conducted a retrospective review of all patients with ASBO from January 1997 to December 2007. Data were categorized by admission date and use of GG. The outcomes reviewed were protocol uptake, median LOS in hospital and operative rate. Results were analyzed using the Mann-Whitney U test and the 2-tailed Fisher exact test.Results: There were 710 patients with ASBO overall. Sixteen of 376 (4.3%) patients received GG before institution of the protocol (period 1), whereas 195 of 334 (58.4%) received GG thereafter (period 2). In period 2, use of GG was limited to between 58% and 69% of all potentially eligible patients per year. Fifty-seven of 710 (8%) patients required surgery. In period 1, there were no significant differences in median LOS in hospital (p = 0.29) and operative rate (p = 0.65) between patients who received GG and those who were managed without GG. In period 2, patients receiving GG had a greater median LOS in hospital (

show abstract

“…Similar observations were made by Kapoor et al, where gastrograffin was given to 24 patients who failed to improve after 48 hours of conservative trial. 11 Contrast radiology was having diagnostic as well as therapeutic value in their study.…”

Section: Discussionmentioning

confidence: 99%

Role of Gastrograffin in the Management of Adhesive Small Bowel Obstruction – A Prospective Study

2010

IJGE

View full text Add to dashboard Cite

Adhesive small bowel obstruction is a major cause of hospital admissions imposing a considerable burden on hospital resources. Early diagnosis and appropriate management of this condition is important to prevent unnecessary surgeries. Various studies have evaluated the efficacy of contrast agents in the management of adhesive small bowel obstruction. We carried out a prospective study to evaluate the diagnostic and therapeutic role of water soluble contrast agent, gastrograffin in patients with adhesive small bowel obstruction. The results of our study concluded that use of gastrograffin in patients with partial small bowel obstruction helps in resolution of symptoms and avoids the need of surgical management in the majority of patients.

show abstract

Prospective Evaluation of Oral Gastrografin in Postoperative Small Bowel Obstruction

Cited by 29 publications

References 18 publications

Clinical Impacts of Oral Gastrografin Follow-Through in Adhesive Small Bowel Obstruction (SBO)

Clinical Impacts of Oral Gastrografin Follow-Through in Adhesive Small Bowel Obstruction (SBO)

Impact of Gastrografin in clinical practice in the management of adhesive small bowel obstruction

Role of Gastrograffin in the Management of Adhesive Small Bowel Obstruction – A Prospective Study

Contact Info

Product

Resources

About